Case report: A sustained survival benefit of third-line immunotherapy for refractory thymic carcinoma
Article in Frontiers in Oncology (July 2024)
The most recent citing publication is shown below. View this citation on Dimensions.
Article in Frontiers in Oncology (July 2024)